Suze Orman Warns Americans Overlook a Major Retirement Expense Offers 4 Strategies Warren Buffetts Tiny Purchase Hint in March May Be Confirmed by Latest Berkshire Filing David Archuletas Memoir Devout Achieves New York Times Bestseller Status Potential for Expanded Revenue Channels Consumer Sentiment Plunges to Record Low in May as Geopolitical Tensions Drive Gas Prices Higher EasyJet FirstHalf Losses Widen as Iran Conflict Drives Fuel Costs Higher and Dents Summer Bookings April Consumer Price Index Surges to 38 Exceeding Expectations ORGO Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges Primoris Services Corporation PRIM Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Confidence AUBN Q1 2026 Earnings Solid EPS of 063 Amid Stable Regional Bank Operations WPP Q4 2025 Earnings EPS Beats Estimates Amid Digital and AIDriven Growth ABXL Q1 2026 Earnings EPS Just Below Estimates Amid Stable Operations APPS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction ABVC BioPharma Inc ABVC Holds Near Support Showing Cautious Recovery Potential Grocery Outlet Holding Corp GO Surges 5 as Discount Retailer Tests Resistance Near 9 Ethan Allen Interiors ETD Holds Steady Near Key Support as Consolidation Continues Equillium Inc EQ Gains Ground as Stock Edges Past Key Support Level DTE Energy Preferred DTB DTB Edges Higher in Quiet Trading Holding Near Support The Late Show With Stephen Colbert Finale Signals Shift in LateNight Television Landscape CVV Q1 2026 Earnings Loss Per Share of 025 as Company Navigates Operational Headwinds BDCI Q1 2026 Earnings Modest Profit Reported Amid Limited Revenue Disclosure Kevin Warsh Faces Internal Fed Divisions Over Interest Rate Policy Amid Inflation and Yield Surge Workday Shares Surge as AI Adoption Drives Margin Outlook Improvement Pluri Inc PLUR Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower Salesforce Shares Dip as Soft Revenue Outlook Raises AI Disruption Concerns CTSO Q1 2026 Earnings Loss Widens as EPS Misses Estimates Stock Gains 642 Neumora Therapeutics NMRA Slides 216 as Stock Tests Key Support Levels